Martin Gajdošík Selected Research

Martin Gajdošík Research Topics

3	Non-alcoholic Fatty Liver Disease 01/2020 - 07/2014
2	Insulin Resistance 01/2020 - 01/2019
1	Brain Concussion (Cerebral Concussion) 01/2023
1	Digestive System Diseases 01/2022
1	Bile Duct Diseases (Bile Duct Disease) 01/2022
1	Body Weight (Weight, Body) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Overweight 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Obesity 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Inflammation (Inflammations) 10/2017
1	Fibrosis (Cirrhosis) 10/2017
1	Hemorrhage 08/2014

3	LipidsIBA 01/2020 - 08/2014
3	Adenosine Triphosphate (ATP)IBA 01/2019 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Liver GlycogenIBA 01/2020 - 01/2019
1	Protons (Proton)IBA 01/2023
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022
1	FructoseIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	GlycogenIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Transaminases (Aminotransferases)IBA 01/2019
1	Antisense OligonucleotidesIBA 01/2019
1	Glucagon Receptors (Glucagon Receptor)IBA 01/2019
1	LDL CholesterolIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Membrane LipidsIBA 10/2017

1	Subcutaneous Injections 01/2019
1	Therapeutics 01/2019